Grants and Contributions

This funding opportunity is expected to:
•Catalyze patient-oriented research aligned with the SPOR Patient Engagement Framework and SPOR Capacity Development Framework by:
¿Developing partnerships amongst patients and patient communities, researchers, health care professionals and health system decision-makers or policy-makers;
¿Mobilizing the above partnerships to develop and conduct a patient-oriented research project or projects; and,
¿Informing future applications for more comprehensive patient-oriented research grants.

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:

• Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
• Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
• Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

This funding opportunity is expected to:

• Advance knowledge through the analysis of existing cohorts, data platforms and/or administrative datasets specific to one of the research areas above.

This funding opportunity is expected to:

• Advance knowledge through the analysis of existing cohorts, data platforms and/or administrative datasets specific to one of the research areas above.

• The Institute of Neurosciences, Mental Health and Addiction (INMHA) will fund an application that is determined to be relevant to the mandate and research priority areas of CIHR-INMHA
o The Institute of Neurosciences, Mental Health and Addiction supports (INMHA) research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.

To provide recognition and funding to academic researchers; to provide a reliable supply of highly skilled and qualified researchers.

The Operating Grant: Methamphetamine and related psychostimulant use is expected to:

• Generate new knowledge around prevalence, incidence, and distribution of methamphetamine use in Canada
• Increase the uptake and application of synthesized knowledge in evidence-based decision-making, health care and/or health services policy and practice in this space
• Support partnerships between researchers and knowledge users to rapidly inform policies related to prevention, harm reduction, and treatment of methamphetamine use
• Address the pressing intervention-related evidence needs of knowledge users in this space
• Encourage implementation science approaches that consider sub-populations and/or the biological and social determinants of methamphetamine use

Through the Institute's programs, researchers address a wide range of health concerns related to infection and immunity including disease mechanisms, disease prevention and treatment, and health promotion through public policy.

Through the Institute's programs, researchers address a wide range of health concerns related to infection and immunity including disease mechanisms, disease prevention and treatment, and health promotion through public policy.

The specific objectives of this funding opportunity are to:
1.Provide women’s health researchers and trainees with operating funds to perform clinical research;
2.Support capacity building in women’s health among the next generation of health researchers; and
3.Start positioning Canada as a leader in women’s health research.